P3 Health Partners Inc. (PIII): Price and Financial Metrics
GET POWR RATINGS... FREE!
PIII Stock Price Chart Interactive Chart >
PIII Price/Volume Stats
|Current price||$4.47||52-week high||$16.73|
|Prev. close||$4.68||52-week low||$3.40|
|Day high||$4.82||Avg. volume||107,370|
|50-day MA||$4.90||Dividend yield||N/A|
|200-day MA||$5.42||Market Cap||180.43M|
P3 Health Partners Inc. (PIII) Company Bio
P3 Health Partners Inc. provides primary health care services. The company offers clinical operations and population health management services, as well as provides senior wellness centers. The company is based in Henderson, Nevada.
Most Popular Stories View All
PIII Latest News Stream
|Loading, please wait...|
PIII Latest Social Stream
View Full PIII Social Stream
Latest PIII News From Around the Web
Below are the latest news stories about P3 HEALTH PARTNERS INC that investors may wish to consider to help them evaluate PIII as an investment opportunity.
HENDERSON, Nev., November 14, 2022--P3 Health Partners, Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter and nine months ended September 30, 2022.
HENDERSON, Nev., November 10, 2022--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company expects to release its financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022. In connection with this announcement, management will host a conference call and provide a corporate and financial update. Details for the conference call are as follows.
HENDERSON, Nev., November 02, 2022--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, is scheduled to participate in a "fireside chat" at the Credit Suisse 31st Annual Healthcare Conference, on Wednesday, Nov. 9, at 2:35 p.m. PST in Rancho Palos Verdes, Calif.
P3 Health Partners Announces Nasdaq’s Confirmation that it has Regained Compliance with Listing Requirements
HENDERSON, Nev., October 27, 2022--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces receipt of an October 24, 2022 letter (the "Compliance Letter") from the Nasdaq Hearing Panel (the "Panel") of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company’s filing delinquency has been cured and that the Company is now in compliance with all applicable listing standards. As a result, the hear
P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results; Increases 2022 Revenue Outlook
Strong First-Half 2022 revenue growth of 84% compared to the First-Half 2021At-risk Medicare Advantage members exceeded 100,000 at the end of the First Half of 2022Net loss PMPM increased to $1,580 in the First Half of 2022 from $135 in the First Half of 2021, primarily due to an $851.5 goodwill impairment chargeAdjusted EBITDA loss PMPM improved significantly in First Half of 2022 at a loss of $78 compared to a PMPM loss of $85 in the First Half of 2021Raising Full-Year 2022 revenue guidance Ma
PIII Price Returns